13Q deletion in predominant cytogenetic aberration newly aquired during chronic lymohocytic leukemia course irrespective of disease activity and treatment status.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	KOTAŠKOVÁ Jana MALČÍKOVÁ Jitka DIVÍŠKOVÁ Eva PAVLOVÁ Šárka MEJSTŘÍKOVÁ Soňa VRÁNOVÁ V. PLEVOVÁ Karla PLEŠINGEROVÁ Hana DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka
Year of publication	2015
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation	KOTAŠKOVÁ, Jana; Jitka MALČÍKOVÁ; Eva DIVÍŠKOVÁ; Šárka PAVLOVÁ; Soňa MEJSTŘÍKOVÁ; V. VRÁNOVÁ; Karla PLEVOVÁ; Hana PLEŠINGEROVÁ; Michael DOUBEK; Jiří MAYER and Šárka POSPÍŠILOVÁ. 13Q deletion in predominant cytogenetic aberration newly aquired during chronic lymohocytic leukemia course irrespective of disease activity and treatment status. In 20th Congress of the European Hematology Association in Haematologica. 2015.
Related projects:	CEITEC - Central European Institute of Technology Molekulární charakterizace B buněčných receptorů a jejich vztah k evoluci genetických změn u chronické lymfocytární leukémie Časná identifikace CLL pacientů s dosud nevyselektovanými mutacemi v proteinu p53 NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia